Aspire for difference...


Located in Cary, N.C., Aspirar Medical Lab offers comprehensive drug testing and monitoring program with superior testing capabilities and personalized services. With highly trained and experienced staff, we provide accurate and consistent diagnostic results within 48 hours for the physicians and medical practices that we serve.


We are nationally licensed and adhere to guidelines stipulated by the Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP). Aspirar Medical Lab is fully accredited and provides services in Pain Management, Drug Testing, Therapeutic Drug Monitoring, and Medical Surveillance.

Aspirar Medical Lab, seen as one of the cutting-edge laboratories in toxicology, is devoted to its clients. We have knowledgeable staff that makes every effort to ensure that relevant clinical information and advanced analytical technologies are applied to each specimen. This ensures that the laboratory test results are highly optimized and have low error validity for the patients. 

Let Aspirar Medical Lab partner with your practice to monitor your patients’ medication compliance and optimize their health.


Call us today at 919-977-9072 to learn more.


At Aspirar Medical Lab, we closely monitor each patient specimen throughout the testing life cycle until results are reviewed and reported to the physician. Results are available within our secure, HIPAA-compliant website, or other method requested.

Coronavirus (COVID-19)
RT-PCR Testing & Vaccines


Our CLIA and COLA accredited laboratory utilizes FDA EUA approved protocols to offer COVID-19 testing using Applied Biosystems' TaqPath COVID-19 Combo Assay. This highly sensitive multiplex diagnostic solution provides real-time detection through PCR technology. We offer several flexible testing options for businesses and individuals alike. We also offer Moderna & Pfizer vaccines. Call us to schedule your vaccine or booster shot today.

Semi-Quantitative Screening & Full Confirmation


We use Enzyme Immunoassay (EIA) to screen for the presence of a drug or metabolite. When positive on the EIA screen, the sample is sent to confirmation for more specific analytical methods, if ordered by the physician. When this semi-quantitative test is positive, full confirmation is available. 

Test Selection
We are committed to our role in educating physicians on the requirement by OIG/HHS that all testing ordered must be deemed medically necessary. As part of our compliance plan, we offer full disclosure of the CPT codes we will bill with, along with the corresponding Medicare fees so that providers may consider those facts as they make their selections.
Medication Monitoring


We offer cutting-edge resources for understanding the specific needs of patients based on their unique biochemistry. In addition, we have pharmacists on staff to answer any medication questions.

Physician Convenience


As a convenience for the physicians and patients, we will pick up the samples at the physician's medical office for test analysis. Results will be available online or integrated into the practices EMR. Also, testing supplies can easily be ordered through the lab.

Coming Soon


Aspirar is excited to announce that we will be offering uninary tract infection, respiratory, and women's health testing services in the near future. Contact us for additional details and check back to see when they will become available.